as 03-28-2025 4:00pm EST
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
Founded: | 1999 | Country: | United States |
Employees: | N/A | City: | NASHVILLE, |
Market Cap: | 68.7M | IPO Year: | 2009 |
Target Price: | N/A | AVG Volume (30 days): | 150.3K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.46 | EPS Growth: | N/A |
52 Week Low/High: | $1.04 - $7.25 | Next Earning Date: | 03-04-2025 |
Revenue: | $37,867,945 | Revenue Growth: | -4.26% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
CPIX Breaking Stock News: Dive into CPIX Ticker-Specific Updates for Smart Investing
PR Newswire
10 days ago
Simply Wall St.
16 days ago
Thomson Reuters StreetEvents
24 days ago
GuruFocus.com
24 days ago
Associated Press Finance
25 days ago
PR Newswire
25 days ago
PR Newswire
a month ago
MT Newswires
a month ago
The information presented on this page, "CPIX Cumberland Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.